Product Name: IL-2 Antibody
Species Reactivity: Human
Tested Applications: ELISA, WB
Applications: ELISA:To detect hIL-2 by direct ELISA (using 100 μL/well antibody solution) a concentration of at least 0.5 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 – 0.4 ng/well of recombinant hIL-2. SandwichTo detect hIL-2 by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5 – 2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with our Biotinylated Anti-Human IL-2 (XP-5181Bt) as a detection antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hIL-2.Western Blot:To detect hIL-2 by Western Blot analysis this antibody can be used at a concentration of 0.1 – 0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-2 is 1.5 – 3.0 ng/lane, under either reducing or non-reducing conditions.
User Note: Centrifuge vial prior to opening.
Predicted Molecular Weight:
Immunogen: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hIL-2 (human Interleukin-2).
Host Species: Rabbit
Purification: Anti-hIL-2 specific antibody was purified by affinity chromatography employing immobilized hIL-2 matrix.
Physical State: Lyophilized
CAS NO.: 37693-01-9
Product: Tauroursodeoxycholate (Sodium)
Buffer:
Concentration:
Storage Conditions: IL-2 antibody is stable for at least 2 years from date of receipt at -20˚C. The reconstituted antibody is stable for at least two weeks at 2-8˚C. Frozen aliquots are stable for at least 6 months when stored at -20˚C. Avoid repeated freeze-thaw cycles.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: IL-2, TCGF, lymphokineInterleukin-2, T-cell growth factor, IL-2
Accession NO.: P60568
Protein Ino: 45593462
Official Symbol: IL2
Geneid: 3558
Background: Interleukin 2 (IL2) is a secreted cytokine that is important for the proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). The expression of this gene in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling the precise expression of a single gene. The targeted disruption of a similar gene in mice leads to ulcerative colitis like disease, which suggests an essential role of this gene in the immune response to antigenic stimuli. IL2 has been shown to have antitumor effects in some studies. This is probably mediated by cytotoxic effector cells.
PubMed ID:http://aac.asm.org/content/26/3/289.abstract
